Compare AYTU & LIQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AYTU | LIQT |
|---|---|---|
| Founded | N/A | 2004 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.5M | 19.3M |
| IPO Year | N/A | N/A |
| Metric | AYTU | LIQT |
|---|---|---|
| Price | $2.33 | $1.88 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $9.33 | $4.20 |
| AVG Volume (30 Days) | ★ 52.7K | 16.6K |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $63,696,000.00 | $16,788,295.00 |
| Revenue This Year | N/A | $34.09 |
| Revenue Next Year | $47.30 | $18.75 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 10.97 |
| 52 Week Low | $0.95 | $1.34 |
| 52 Week High | $2.82 | $3.35 |
| Indicator | AYTU | LIQT |
|---|---|---|
| Relative Strength Index (RSI) | 60.88 | 40.45 |
| Support Level | $2.05 | $1.81 |
| Resistance Level | $2.39 | $2.14 |
| Average True Range (ATR) | 0.10 | 0.11 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 78.57 | 2.47 |
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.